Better Infection Prevention with On-Demand Molecular Diagnostics

Better and faster answers from diagnostic tests enable clinicians to enhance treatment and infection prevention efforts.

Only Cepheid delivers these fast and accurate results so you can:

  • Get easy to interpret answers for more cost-effective patient management1

  • Improve implementation of infection prevention policies2

  • Support better clinical decisions to improve patient outcomes3

  • Reduce the number of surgical site infections by using targeted decolonization strategies4

  • Elevate antibiotic stewardship and reduce unnecessary therapy costs4

  • Minimize follow-up visits by optimizing treatment early5

    

Four Core Actions to Fight Infections & Antimicrobial Resistance

1

Preventing the Spread

2

Tracking Resistant Bacteria

3

Improving Antibiotic Prescribing and Stewardship

4

Preventing the Spread

Impact of Rapid Diagnostics

Shortened hospital length of stay by 2.5 days3

Decreased lethal bloodstream infections in patients by 36%3

Reduced time to effective therapy by 5 hours3

Related Product Links

Xpert® Carba-R

Xpert® Carba-R

Détection et différenciation de KPC, NDM, VIM, IMP et OXA-48 en 50 minutes
Xpert® MRSA NxG

Xpert® MRSA NxG

Tests de surveillance active des SARM en 70minutes environ.
Xpert® SA Nasal Complete

Xpert® SA Nasal Complete

Test préopératoire du portage de S. aureus et SARM en 65 minutes environ
Xpert® MRSA/SA Blood Culture

Xpert® MRSA/SA Blood Culture

Détection précise de SARM et de S. aureus à partir d’échantillons d’hémoculture positifs en une heure environ
Xpert® MRSA/SA SSTI

Xpert® MRSA/SA SSTI

Détection des infections de la peau et des tissus mous à SARM & à SA en une heure environ
Xpert® CT/NG

Xpert® CT/NG

Diagnostic rapide et précis des infections à chlamydia et gonorrhea
Xpert® TV

Xpert® TV

Diagnostic rapide et précis de la trichomonase en 90 minutes ou moins
Xpert® Xpress Strep A

Xpert® Xpress Strep A

Test de PCR qualitative en temps réel assurant une détection précise des streptocoques du groupe A en seulement 18 minutes.

1. Casari E, et al. Reducing rates of Clostridium difficile infection by switching to a stand-alone NAAT with clear sampling criteria. Antimicrob Resist Infect Control. 2018;7:40.

2. Birgand G, et al. Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Resist Infect Control. 2013 Nov 4;2(1):30.

3. Bauer KA, et al. An Antimicrobial Stewardship Program’s Impact with Rapid olymerase chain reaction methicillin-resistant/ Staphylococcus Blood Culture Test in Patients with Staphylococcus Bacteremia. Clin Infect Dis. 2010; 51(9):1074–1080.

4. Humphreys H, et al. Staphylococcus and surgical site infections: benefits of screening and decolonization before surgery. J Hosp Infect. 2016. Nov;94(3):295-304.

5. Rudd K, et al. Molecular Diagnostics Can Lead To Early Optimization of Antimicrobial Therapy for Staphylococcal Bacteremia: Experience at a Large Tertiary-Care VA Medical Center. Open Forum Infectious Diseases, Volume 3, Issue suppl_1, 1 December 2016, 1863. Accessed 12 July 2018.